Drug Patent Challenge Report profiles companies that successfully challenged pharmaceutical drugs
DrugPatentWatch.com introduces Drug Patent Challenge Report
General Biotechnology
General Biotechnology
Orphan Drug Exclusivity profiles FDA-approved Orphan Drugs
DrugPatentWatch.com announces new Orphan Drug Exclusivity report
Orphan Drug Exclusivity profiles FDA-approved Orphan Drugs Read Post »
General Biotechnology
Orphan Drug Report
I’ve posted a new Orphan Drug Report at thinkPharm.com. This new report complements the Drug Patent Inventor Report, and profiles
General Biotechnology
Bio Bank Helps Lethal Brain Cancer Patient Maintain Tissue Ownership Defy the Odds
HealthBank empowering patients with full ownership and control of their stored tumor tissue integral for tailored treatment courses; Six-year brain
Bio Bank Helps Lethal Brain Cancer Patient Maintain Tissue Ownership Defy the Odds Read Post »
General Biotechnology
Coming soon – Biotechnology Entrepreneurship: From Science to Solutions
Coming soon, a book by Michael L. Salgaller, PhD. In this new book — Biotechnology Entrepreneurship: From Science to Solutions
Coming soon – Biotechnology Entrepreneurship: From Science to Solutions Read Post »
General Biotechnology
Synthetic Biology: Revolutionary or Evolutionary
Synthetic biology has been hailed as a revolution in biotechnology, enabling bold new possibilities in areas such as energy production,
Synthetic Biology: Revolutionary or Evolutionary Read Post »
General Biotechnology
Profile drugs with FDA regulatory exclusivity
DrugPatentWatch.com adds new search functionality
General Biotechnology
Broad Institute acquires license to all ChemAxon products and deploys across Chemical Biology Platform.
Compound registration, structure search and computed properties rolled out. Budapest, Hungary and Cambridge, Massachusetts, 19 August 2010 – ChemAxon, a
General Biotechnology
BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine
Ness Ziona, Israel – 17 August 2010 – BiondVax Pharmaceuticals Ltd. (TASE: BNDX), an Israeli biopharmaceutical company at the forefront
General Biotechnology
Headwaters MB Adds to Life Sciences Team
Headwaters MB announced that Don Warriner and Brad Rosborough have joined the firm as Managing Directors within the Life Sciences
